A long-term, open-label trial of the safety and efficacy of etanercept (25 mg twice weekly) in patients with rheumatoid arthritis (interim analysis of 4-year data)

被引：0
|
作者：
Klareskog, L [1 ]
Wajdula, J [1 ]
Pedersen, R [1 ]
机构：
[1] Karolinska Hosp, Rheumatol Unit, S-10401 Stockholm, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [1] A long-term, open-label trial of the safety and efficacy of etanercept (25 mg twice weekly) in patients with rheumatoid arthritis (interim analysis).
    Wajdula, J
    Pedersen, R
    Sanda, M
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S229 - S229
  • [2] A long-term, open-label trial of the safety and efficacy of etanercept (25 mg twice weekly) in patients with rheumatoid arthritis (interim analysis).
    Willis, RF
    Pedersen, R
    [J]. JOURNAL OF RHEUMATOLOGY, 2001, 28 : 101 - 101
  • [3] A long-term, open-label trial of the safety and efficacy of etanercept (25 mg twice weekly) in patients with rheumatoid arthritis (final 5-year data)
    Klareskog, L
    Wajdula, J
    Pedersen, R
    Yeh, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 254 - 254
  • [4] A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis
    Lee, Joo-Heung
    Youn, Jai-Il
    Kim, Tae-Yoon
    Choi, Jee-Ho
    Park, Chul-Jong
    Choe, Yong-Beom
    Song, Hae-Jun
    Kim, Nack-In
    Kim, Kwang-Joong
    Lee, Jeung-Hoon
    Yoo, Hyun-Jeong
    [J]. BMC DERMATOLOGY, 2016, 16
  • [5] Evaluation of the efficacy and safety of etanercept 50 mg once weekly in Japanese patients with rheumatoid arthritis and comparison with 25 mg etanercept twice weekly
    Mochizuki, Takeshi
    Momohara, Shigeki
    Yano, Koichio
    Shirahata, Toshikatsu
    Ikari, Katsunori
    [J]. MODERN RHEUMATOLOGY, 2013, 23 (05) : 994 - 1000
  • [6] Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis
    Tyring, Stephen
    Gordon, Kenneth B.
    Poulin, Yves
    Langley, Richard G.
    Gottlieb, Alice B.
    Dunn, Meleana
    Jahreis, Angelika
    [J]. ARCHIVES OF DERMATOLOGY, 2007, 143 (06) : 719 - 726
  • [7] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [8] Long-term efficacy and safety with zonisamide: Interim analysis of an open-label study
    Wroe, S
    Brodie, MJ
    [J]. EPILEPSIA, 2005, 46 : 118 - 118
  • [9] A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs
    Klareskog, L.
    Gaubitz, M.
    Rodriguez-Valverde, V.
    Malaise, M.
    Dougados, M.
    Wajdula, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (12) : 1578 - 1584
  • [10] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
    Feist, Eugen
    Nasonov, Evgeny
    Luggen, Michael
    Fatenejad, Saeed
    Grishin, Sergey
    Samsonov, Mikhail
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
12345